📰 Michael Yee News
Page 32 - Michael Yee News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Yee. Real-time updates on events, politics, business and more.
March 14, 2022
Shares of Moderna, BioNTech, Pfizer, Johnson & Johnson and Novavax rose on Monday as China battles its worst Covid outbreak in two years.
March 14, 2022
Shares of Moderna, BioNTech, Pfizer, Johnson & Johnson and Novavax rose on Monday as China battles its worst Covid outbreak in two years.
March 11, 2022
A closer look at the strategies that proved most popular over the past month, as well as those investors withdrew their cash from.
March 10, 2022
Moderna is still heavily reliant on revenue from its Covid-19 vaccine, but the biotech firm must diversify to strengthen its long-term position.
March 3, 2022
Market analysts are debating what future Covid vaccine demand will look when Covid becomes an endemic, seasonal virus.
March 1, 2022
AMRN earnings call for the period ending December 31, 2021.
February 25, 2022
Moderna Inc. executives said on Thursday they believe a fourth COVID-19 vaccine shot will be needed late this ...
February 25, 2022
Moderna Inc executives said on Thursday they believe a fourth COVID-19 vaccine shot will be needed late this year due to waning protection from earlier doses, which could push up sales in the second... | February 25, 2022
February 24, 2022
This year, Moderna expects revenue from sales of its mRNA-based COVID-19 vaccine to clock in at around $22 billion. The company has locked up advanced purchase agreements worth $19 billion, with additional signed options valued at roughly $3 billion, the company said Thursday.
February 24, 2022
MRNA earnings call for the period ending December 31, 2021.